Serum Amyloid A Blocking Peptide
Référence MBS9622004-1mg
Conditionnement : 1mg
Marque : MyBiosource
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
Serum Amyloid A Blocking Peptide – The purity is >90%,tested by HPLC and MS. Purity
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9622004Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the… More details
Product Overview
Online Datasheet in PDFProduct Name
Serum Amyloid A (Saa1), Blocking Peptide
Full Product Name
Serum Amyloid A Blocking Peptide
Product Gene Name
Saa1 blocking peptide
Form/Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.
Purity/Purification
The purity is >90%,tested by HPLC and MS.
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.
Antibody/Peptide Pairs
Serum Amyloid A peptide (MBS9622004) is used for blocking the activity of Serum Amyloid A antibody (MBS9612060)
Molecular Weight
13,770 Da
Supply Chain Verification
Manufactured in a lab with traceable raw materials manufactured on site. Coordinated product portfolio of antibodies, pairs, conjugates, recombinant proteins, and immunoassay materials available, please inquire.
Notes
For phospho antibody, we provide phospho peptide (0.5mg) and non-phospho peptide (0.5mg)
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for Saa1 blocking peptide
Blocking/Control
Related Product Information for Saa1 blocking peptide
Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (immunoblot) and immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or immunostaining performed with the neutralized antibody.
Other Notes
Small volumes of Saa1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for Saa1 purchase
MBS9622004 is a blocking peptide targeting Saa1. Also known as Serum Amyloid A Blocking Peptide.
Additional Details
NCBI/Uniprot data below describe general gene information for Saa1. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
serum amyloid A-1 protein
NCBI Official Synonym Full Names
serum amyloid A 1
NCBI Official Symbol
Saa1
NCBI Official Synonym Symbols
Saa2; Saa-1
UniProt Protein Name
Serum amyloid A-1 protein
Protein Family
Amyloid protein
UniProt Gene Name
Saa1
NCBI Protein Information
serum amyloid A-1 protein
UniProt Comments for Saa1
Major acute phase protein.
Research Articles on Saa1
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with Saa1 blocking peptide
| Reference Product | PubMed Publications |
|---|---|
| Saa2 blocking peptide | >163 publications with Saa1 and Saa2 |
| Cxcl1 blocking peptide | >5 publications with Saa1 and Cxcl1 |
| Apoa1 blocking peptide | >3 publications with Saa1 and Apoa1 |
| Cxcl5 blocking peptide | >2 publications with Saa1 and Cxcl5 |
| Apcs blocking peptide | >2 publications with Saa1 and Apcs |
| Ccl20 blocking peptide | >1 publications with Saa1 and Ccl20 |
Diseases associated with Saa1 blocking peptide
| Disease Name | Pubmed Publications |
|---|---|
| Inflammation Antibodies | >135 publications with Saa1 and Inflammation |
| Necrosis Antibodies | >36 publications with Saa1 and Necrosis |
| Cardiovascular Diseases Antibodies | >26 publications with Saa1 and Cardiovascular Diseases |
| Liver Diseases Antibodies | >25 publications with Saa1 and Liver Diseases |
| Disease Models, Animal Antibodies | >24 publications with Saa1 and Disease Models, Animal |
| Kidney Diseases Antibodies | >24 publications with Saa1 and Kidney Diseases |
| Atherosclerosis Antibodies | >23 publications with Saa1 and Atherosclerosis |
| Liver Neoplasms Antibodies | >15 publications with Saa1 and Liver Neoplasms |
| Lung Diseases Antibodies | >14 publications with Saa1 and Lung Diseases |
| Carcinoma, Hepatocellular Antibodies | >12 publications with Saa1 and Carcinoma, Hepatocellular |
Organs/Tissues associated with Saa1 blocking peptide
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Liver Antibodies | >95 publications with Saa1 and Liver |
| Lung Antibodies | >20 publications with Saa1 and Lung |
| Intestine Antibodies | >18 publications with Saa1 and Intestine |
| Mammary Gland Antibodies | >7 publications with Saa1 and Mammary Gland |
| Uncharacterized Tissue Antibodies | >1 publications with Saa1 and Uncharacterized Tissue |